-
EUR RADIOL 2020 10.1007/s00330-019-06575-0
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Lee1, MW; Kang, D; Lim, HK; Cho, J; Sinn, DH; Kang, TW; Song, KD; Rhim, H; Cha, DI; Lu, DSK
View PubMed
-
CARDIOVASC INTER RAD 2020 10.1007/s00270-019-02394-4
RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes
Cha1, SY; Kang, TW; Min, JH; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Park, MS
View PubMed
-
BRIT J RADIOL 2020 10.1259/bjr.20190719
Small masses (<= 3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation
Cha1, DI; Song, KD; Kang, TW; Lee, MW; Rhim, H
View PubMed
-
EUR RADIOL 2019 10.1007/s00330-018-5993-y
Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival
Lee1, DH; Lee, JM; Kim, PN; Jang, YJ; Kang, TW; Rhim, H; Seo, JW; Lee, YJ
View PubMed
-
Abdom Radiol (NY) 2019 10.1007/s00261-019-01952-1
Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy
Kim1, W; Cho, SK; Shin, SW; Hyun, D; Lee, MW; Rhim, H
View PubMed
